Accessibility Menu
Banyan logo

Banyan(OTC) BNYN

Current Price$0.00
Market Cap$1.50KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1996)-100%
5 Year+0%
1 Year-99%
1 Month+0%
Banyan last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-24
Banyan stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-06-26
1 month+0%USD 0.002026-06-24
3 month-99.48%USD 0.002025-07-23
Year to date-99.48%USD 0.002025-07-23
1 year-99.48%USD 0.002025-07-23
3 year+0%USD 0.002023-07-18
5 year+0%USD 0.002021-07-21
Since inception-100%USD 1,300,000.001996-05-01

Banyan Financials at a Glance

Market Cap

$1.50KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$3.48M

Net Income (TTM)

-$4.00M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-14.00 (Low)

Price

$0.00

Volume

205

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

BNYN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Banyan

Banyan Corp. is a healthcare company focused on franchising chiropractic clinics across North America. The company also provides essential diagnostic testing services, including Nerve Conduction Velocity (NCV) testing, and manufactures the proprietary VT3000 nerve testing system.

Products and Services
  • Franchising chiropractic clinics throughout North America
  • Nerve Conduction Velocity (NCV) testing services
  • Manufacturing and marketing of the VT3000 nerve testing system
Growth Outlook
  • Expansion of franchise locations expected to drive revenue growth
  • Increasing demand for diagnostic testing services in healthcare
  • Investment in technology to enhance service offerings and efficiency
Financial Highlights
  • Recent quarterly revenue of 696,364, showing a positive trend
  • Gross profit margin remains strong at 100% for the latest quarter
  • Operating cash flow improved to 256,834 in the most recent quarter
Banyan Corp. operates in the medical care facilities industry, providing a unique blend of franchising and diagnostic services. The company's focus on chiropractic care positions it well within a growing healthcare sector. Recent financial data indicates a positive trajectory, with a notable increase in quarterly revenue and a strong gross profit margin. The operating cash flow improvement suggests enhanced operational efficiency, which may attract potential investors looking for growth opportunities in the healthcare market. The strategic expansion of franchise locations and the rising demand for diagnostic services further bolster the company's growth outlook.
AI Generated • Jul 22, 2026

Industry

Healthcare Providers and Services

Headquarters

Beverly Hills, CA 90211, US

BNYN Financials

Key Financial Metrics (TTM)

Gross Margin

100.00%

Operating Margin

-31.85%

Net Income Margin

-109.58%

Return on Equity

-1409.54%

Return on Capital

-43.74%

Return on Assets

-121.77%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.50KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.51B

Volume

205

Avg. Volume

165.40K

Financials (TTM)

Gross Profit

$3.48M

Operating Income

-$1.21M

EBITDA

-$1.02M

Operating Cash Flow

-$163.42K

Capital Expenditure

-$6.18K

Free Cash Flow

-$169.60K

Cash & ST Invst.

$66.58K

Total Debt

$4.36M

Banyan Performance Analysis

Banyan sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32007-09-30-13.9%
Q42007-12-31-10.9%
Q12008-03-31-44.8%
Q22008-06-3021.2%
Banyan sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32007-09-3059.8%
Q42007-12-31-24.5%
Q12008-03-3187.9%
Q22008-06-3051.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2008YOY CHG

Revenue

$696.36K

-48.7%

Gross Profit

$696.36K

-48.5%

Gross Margin

100.00%

N/A

Market Cap

$1.50KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$75.00

N/A

Employees

20

N/A

Net Income

-$849.10K

+49.4%

EBITDA

-$45.44K

+28.4%

Quarterly Fundamentals

Name
Q2 2008YOY CHG

Total Cash

$66.58K

+3.4%

Total Debt

$4.36M

+25.5%

Accounts Receivable

$1.20M

-46.3%

Inventory

$0.00

N/A

Long Term Debt

$1.57M

-32.4%

Short Term Debt

$2.79M

+141.3%

Return on Assets

-1.22%

N/A

Return on Invested Capital

-65.97%

N/A

Free Cash Flow

$256.83K

+154.2%

Operating Cash Flow

$256.83K

+156.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TOMDFTodos Medical Ltd.
$0.00+0.00%
NEPTFNeptune Wellness Solutions Inc.
$0.00+0.00%
PHRXPharmagen, Inc.
$0.00+0.00%
SCRCQScripsAmerica, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.23+0.10%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.22-0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$62.79-0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$45.62+0.02%

Questions About BNYN

What is the current price of Banyan?

Banyan is trading at $0.00 per share.

What is the 52-week range for Banyan?

Over the past 52 weeks, Banyan has traded between $0.00 and $0.00.

How much debt does Banyan have?

Banyan total debt is unavailable.

How much cash does Banyan have on hand?

Banyan does not have cash on hand data available.

What is Banyan’s dividend yield?

Banyan does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.